| 注册
首页|期刊导航|临床肝胆病杂志|HBV母婴零传播——从争议到共识

HBV母婴零传播——从争议到共识

刘志华 侯金林

临床肝胆病杂志2024,Vol.40Issue(11):2137-2140,4.
临床肝胆病杂志2024,Vol.40Issue(11):2137-2140,4.DOI:10.12449/JCH241101

HBV母婴零传播——从争议到共识

Toward zero mother-to-child transmission of hepatitis B virus:From controversy to consensus

刘志华 1侯金林1

作者信息

  • 1. 南方医科大学南方医院感染内科,广东省肝脏疾病研究所,广州 510515
  • 折叠

摘要

Abstract

Mother-to-child transmission is the major route of transmission for hepatitis B virus(HBV),and prevention of the mother-to-child transmission of HBV is the key link in the prevention and control of hepatitis B and one of the five essential core strategies for achieving the global elimination of hepatitis B by 2030.Combined immunization for neonates born to HBV-infected mothers and maternal antiviral intervention during pregnancy are important measures for blocking mother-to-child transmission,and thereby,the implementation of the comprehensive strategy of combined immunization and maternal antiviral intervention will help to accelerate the process of eliminating mother-to-child transmission.Chinese scholars have put forward the concept of"zero mother-to-child transmission of hepatitis B"and launched"Shield Program"in China,aiming to promote the implementation of the preventive strategy for mother-to-child transmission and lay a solid foundation for eliminating viral hepatitis in China.The Shield Program has provided detailed implementation strategies,successful practice experience,and reliable data for blocking the mother-to-child transmission of hepatitis B,fostering the consensus on the zero mother-to-child transmission of HBV in the academic community,and it also has an important reference value for eliminating the mother-to-child transmission of HBV in China and globally.

关键词

乙型肝炎病毒/传染性疾病传播,垂直/"小贝壳"项目

Key words

Hepatitis B Virus/Infectious Diseases Transmission,Vertical/"Shield"Program

引用本文复制引用

刘志华,侯金林..HBV母婴零传播——从争议到共识[J].临床肝胆病杂志,2024,40(11):2137-2140,4.

基金项目

国家重点研发计划(2022YFC2303600) National Key Research and Development Program of China(2022YFC2303600) (2022YFC2303600)

临床肝胆病杂志

OA北大核心CSTPCD

1001-5256

访问量0
|
下载量0
段落导航相关论文